跳到主要內容
Rallybid

籌劃中

RFI: Digital Technologies for Contact Tracing, Infection Surveillance & Response

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency已就「RFI: Digital Technologies for Contact Tracing, Infection Surveillance & Response」發布此招標,現已不再接受新的投標。

此招標已不再接受新的投標。 類似的進行中招標

用淺白語言說明,這項招標是什麼?

此公告尚未翻譯,以原文語言顯示。

同類招標的過往批出紀錄說明了甚麼?

  • 同類招標平均每項約有 2.6 份投標(132 項批出紀錄載有數目)。
  • 半數同類合約的批出金額介乎 £95,858 至 £861,915,中位數為 £249,480。

根據過去 36 個月 867 項批出紀錄:相同工種、相同地區。可信程度:高。以上只反映過往情況,並非預測結果。 批出合約資料

誰贏得這項招標,金額是多少?

此招標尚未公布批出結果。

公告全文

原文(English)

RFI: Digital Technologies for Contact Tracing, Infection Surveillance & Response

The UK Health Security Agency (UKHSA) is seeking to understand the market's ability to deliver digital technologies that support public health intervention activities such as, but not limited to, surveillance, infection identification, the management of cases, contacts and exposures during a health emergency. The objective of this Request for Information (RFI) is to inform future preparedness planning and ensure the UK has access to scalable, effective and deployable digital capabilities that can help reduce transmission, improve situational awareness and support public health interventions during a pandemic or other infectious disease emergency. The key dates for this RFI are as follows: RFI Published: 18th September 2026 RFI Response Deadline: 2nd October 2026 Specifically, UKHSA wishes to: I. Understand the current and emerging marketplace for digital technologies that could be deployed during a future pandemic or infectious disease incident to support the prevention, identification, monitoring and management of infection transmission among the population, across a range of pathogens and settings. II. Understand the intended purpose, use cases and operational objectives of technologies currently available or under development, including solutions not specifically designed for pandemic response but which may have utility in supporting infection control measures, population monitoring, exposure identification or public communications during a health emergency. III. Assess the effectiveness, maturity and performance characteristics of different intervention, surveillance and outbreak-management technologies, including evidence of impact, operational limitations and suitability for deployment across diverse settings such as communities, healthcare facilities, care homes, schools and other educational establishments, custodial environments, travel and transportation hubs, and workplaces. IV. Understand the costs associated with the implementation, operation and maintenance of technologies across different deployment scenarios, including infrastructure, licensing, support, integration and user adoption requirements, to inform assessments of affordability and value for money. V. Understand suppliers' manufacturing, delivery and operational capacity (inclusive of lead times), including their ability to rapidly scale deployment during a national emergency, and identify key dependencies, risks, constraints and mitigation approaches that may affect resilience of supply. VI. Assess industry capability to develop, adapt or configure bespoke digital solutions that support activities such as case management, contact tracing, exposure notification, outbreak investigation, provision of personalised advice, and wider population engagement, including the ability to provide interoperable data flows into UKHSA systems in near real time while meeting relevant legal, data protection, security and governance requirements. VII. Refine UKHSA's understanding of requirements by identifying innovative approaches, emerging technologies and alternative delivery models that may improve public health outcomes, operational effectiveness, user experience and scalability for Pandemic and other large scale public health incidents. VIII. Inform UKHSA's future commercial strategy and route-to-market approach, ensuring procurement requirements are proportionate, deliver value for money, maximise competition and innovation, and support the acquisition of capabilities that are fit for purpose during health emergencies. Should you wish to respond to this Request for Information or require more information, please follow the link below: https://atamis-1928--prospend.vf.force.com/apex/CS_ContractPage?filters=&page=1&Preview=Yes&searchStr=&SearchType=Projects&sortStr=Alphabetical&uid=a07Pz00001wm4S4IAI&sfdcIFrameOrigin=https%3A%2F%2Fatamis-1928.lightning.force.com

以電郵接收這些招標

每天一封電郵,列出你所選行業及地區的新招標。無需帳戶或密碼。

我們會先以電郵發送確認連結。在你使用連結之前,不會發送任何其他內容。 私隱聲明

快速解答

這項招標何時截止?

公告沒有列明截止日期。請查閱採購方的入口網站。

這份合約價值多少?

公告沒有列明價值。

採購方是誰?

採購方是Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency。

同類招標通常有多少企業投標?

同類招標平均每項約有 2.6 份投標(132 項批出紀錄載有數目)。 根據過去 36 個月 867 項批出紀錄:相同工種、相同地區。可信程度:高。以上只反映過往情況,並非預測結果。

類似的進行中招標